chr5-140631764-A-T
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2
The NM_000591.4(CD14):c.*92T>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00221 in 1,186,312 control chromosomes in the GnomAD database, including 35 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.010 ( 19 hom., cov: 32)
Exomes 𝑓: 0.0010 ( 16 hom. )
Consequence
CD14
NM_000591.4 3_prime_UTR
NM_000591.4 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.123
Genes affected
CD14 (HGNC:1628): (CD14 molecule) The protein encoded by this gene is a surface antigen that is preferentially expressed on monocytes/macrophages. It cooperates with other proteins to mediate the innate immune response to bacterial lipopolysaccharide, and to viruses. This gene has been identified as a target candidate in the treatment of SARS-CoV-2-infected patients to potentially lessen or inhibit a severe inflammatory response. Alternative splicing results in multiple transcript variants encoding the same protein. [provided by RefSeq, Aug 2020]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0102 (1552/152326) while in subpopulation AFR AF= 0.035 (1457/41574). AF 95% confidence interval is 0.0335. There are 19 homozygotes in gnomad4. There are 730 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 19 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD14 | NM_000591.4 | c.*92T>A | 3_prime_UTR_variant | 2/2 | ENST00000302014.11 | NP_000582.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD14 | ENST00000302014.11 | c.*92T>A | 3_prime_UTR_variant | 2/2 | 1 | NM_000591.4 | ENSP00000304236 | P1 | ||
CD14 | ENST00000498971.7 | c.*92T>A | 3_prime_UTR_variant | 3/3 | 2 | ENSP00000426543 | P1 | |||
CD14 | ENST00000512545.2 | c.*92T>A | 3_prime_UTR_variant | 3/3 | 3 | ENSP00000425447 | P1 | |||
CD14 | ENST00000519715.2 | c.*92T>A | 3_prime_UTR_variant | 3/3 | 4 | ENSP00000430884 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0102 AC: 1552AN: 152208Hom.: 19 Cov.: 32
GnomAD3 genomes
AF:
AC:
1552
AN:
152208
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00103 AC: 1068AN: 1033986Hom.: 16 Cov.: 13 AF XY: 0.000896 AC XY: 463AN XY: 516550
GnomAD4 exome
AF:
AC:
1068
AN:
1033986
Hom.:
Cov.:
13
AF XY:
AC XY:
463
AN XY:
516550
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0102 AC: 1552AN: 152326Hom.: 19 Cov.: 32 AF XY: 0.00980 AC XY: 730AN XY: 74484
GnomAD4 genome
AF:
AC:
1552
AN:
152326
Hom.:
Cov.:
32
AF XY:
AC XY:
730
AN XY:
74484
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
11
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at